Pfizer Inc (NYSE:PFE)

Thursday’s trading has closed, but PFE is being traded in the after-hours session. After-Hours quote »
30.71
Data as of 4:00pm ET
 -0.21 / -0.68%
Today’s Change
27.12
Today|||52-Week Range
32.96
+0.26%
Year-to-Date
3 Drugs Johnson & Johnsonbs Investors Better Know About
6:30pm / MotleyFool.com
Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)
Apr 22 / Benzinga
Market Wrap For April 24: Apple's Smashing Earnings Overshadowed By Ukraine Concerns
5:46pm / Benzinga
This is the 1 Thing AstraZeneca Should Do to Improve Shareholder Value
Apr 22 / MotleyFool.com
AstraZeneca (AZN) Stock Higher Over Pfizer (PFE) Takeover Talk As Earnings Drop
12:36pm / TheStreet.com
3 Health Care Stocks Moving The Sector Upward
Apr 22 / TheStreet.com
Dow Today: Pfizer (PFE) Lower
11:19am / TheStreet.com
Novartis Reshapes Portfolio via GSK, Eli Lilly Deals
Apr 22 / TheStreet.com
Trade-Ideas: Pfizer (PFE) Is Today's "Roof Leaker" Stock
10:32am / TheStreet.com
Stock Market News for April 22, 2014 - Market News
Apr 22 / Zacks.com
Zimmer agrees $13.4bn Biomet acquisition
10:30am / FT.com
Today's Health-Care Stocks to Watch: Allergan, Inc., AstraZeneca, Pfizer, and Valeant...
Apr 22 / MotleyFool.com
Is This Struggling Drugmaker Worth $100 Billion?
9:31am / MotleyFool.com
Botox maker gets $46 billion bid
Apr 22 / CNNMoney.com
#PreMarket Primer: Thursday, April 24: FDA & FCC Rolling Out Key Decisions, Apple Mak...
8:31am / Benzinga
Stocks: Pharma, earnings in the spotlight
Apr 22 / CNNMoney.com
AstraZeneca: sweetener for jam tomorrow
7:44am / FT.com
Netflix Jumps on Earnings; Ford Taps Next CEO
Apr 21 / MotleyFool.com
Merck, P&G and Other Dividend Stocks You Wish You'd Bought in 2013
6:07am / TheStreet.com
Dow Climbs As Pharma Stocks Jump, but Will Drug M&A Hurt UnitedHealth?
Apr 21 / MotleyFool.com
European Stocks Rebound Amid M&A, Earnings Headlines
6:02am / TheStreet.com
Ackman drives bid for Botox maker Allergan
Apr 21 / FT.com
Stocks: Buoyed by Apple, Facebook
4:59am / CNNMoney.com
The Biggest Biotech Wins of the Week
Apr 21 / MotleyFool.com
AstraZeneca upbeat over R&D pipeline
3:29am / FT.com
Pfizer, Inc. Rebuffed: Is AstraZeneca plc Worth Another Try?
Apr 21 / MotleyFool.com
Encouraging Results from Pfizer's Xeljanz - Analyst Blog
Apr 23 / Zacks.com
Market Wrap For April 21: S&P 500 Extends Winning Streak To Five Days, Dow & Nasdaq A...
Apr 21 / Benzinga
Will These 3 Dividend Stocks Impress Investors This Earnings Season?
Apr 23 / MotleyFool.com
Supreme Court Denies Teva's Request - Analyst Blog
Apr 21 / Zacks.com
The future of pharma lies in research, not cost-cutting
Apr 23 / FT.com
Pfizer Inc (PFE): Today's Featured Drugs Winner
Apr 21 / TheStreet.com
Cubist Pharma Posts Weak Earnings on Soft Cubicin Sales - Analyst Blog
Apr 23 / Zacks.com
Is Pfizer Eyeing AstraZeneca? - Analyst Blog
Apr 21 / Zacks.com
'Croci' pushes the limits of value investing
Apr 23 / FT.com
Pfizer's Missed Megadeal Sparks the Dow's Rise
Apr 21 / MotleyFool.com
Stock Market News for April 23, 2014 - Market News
Apr 23 / Zacks.com
Warfarin's Loss is Johnson & Johnson's Gain
Apr 21 / MotleyFool.com
Amgen's Q1 Earnings Decline Y/Y - Analyst Blog
Apr 23 / Zacks.com
Dow Today: Pfizer (PFE) Higher
Apr 21 / TheStreet.com
Celgene to Rise Like a Phoenix: Opinion
Apr 23 / TheStreet.com
Big pharma deals are back in the mix
Apr 21 / FT.com
A Doozy of a Pharma Rumor
Apr 22 / MotleyFool.com
Pfizer approach raises questions over UK's takeover stance
Apr 21 / FT.com
Billionaire Ken Fisher's Top Stock Picks
Apr 22 / MotleyFool.com
Why Pfizer (PFE) Stock Is Up Today
Apr 21 / TheStreet.com
5 reasons to care about Ackman's Botox bet
Apr 22 / CNNMoney.com
Mid-Day Market Update: AMD Surges After Upbeat Results; Acacia Research Shares Declin...
Apr 21 / Benzinga
Deals fever grips pharmaceuticals industry
Apr 22 / FT.com
Pfizer / AstraZeneca: combination therapy
Apr 21 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.